Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

SSE reports solid operational performance

(Sharecast News) - SSE said in an update on Wednesday that it expects full-year adjusted earnings per share for 2024-2025 to range between 154p and 163p, reflecting solid operational performance amid variable weather conditions in the third quarter. The FTSE 100 power giant confirmed that expectations for business unit operating profit remained unchanged.

It said renewables output for the first three quarters of the financial year was 26% higher than the same period last year, driven by additional capacity and weather conditions.

January brought further variability in renewables generation, but overall, SSE's electricity networks division has continued to deliver strong operational performance.

The company cautioned that full-year earnings remained subject to factors including market conditions, weather, and plant performance over the final quarter.

An update on performance for the remainder of the year would be released on 2 April.

SSE said that strategically, SSEN Transmission had published its RIIO-T3 Business Plan, outlining at least £22bn in critical grid infrastructure investment over the five years to 2031, supporting UK and Scottish energy security and net zero goals.

The plan included a potential additional £9.4 billion in expenditure, bringing the total to around £32bn, with the company expecting to complete planning submissions for its remaining ASTI projects in the coming months.

SSE Renewables meanwhile continued its expansion, with first power achieved at the 101MW Yellow River onshore wind farm and a financial investment decision reached on the 208MW Strathy South onshore wind project.

The first phase of the Dogger Bank offshore wind farm remains on track for completion in the second half of 2025, with SSE securing a second installation vessel from 2026 to support the project's later phases.

SSE Thermal had meanwhile taken a final investment decision on the 300MW Tarbert Next Generation power station in Ireland, which would run on sustainable biofuel and was backed by a 10-year capacity agreement.

The facility was expected to be operational by late 2027.

Additionally, SSE said it secured 522MW of de-rated electricity generation capacity in Ireland's T-4 2028-2029 capacity auction, with a significantly increased clearing price of €149,960 per MW.

"We are pleased to report good operational performance during the quarter and, more recently, we were able to provide a swift and effective response to Storm Eowyn, with our teams expertly managing widespread network disruption," said chief financial officer Barry O'Regan.

"Looking further ahead, our resilient and balanced business mix continues to give us confidence in achieving targeted adjusted earnings per share of between 175p and 200p in 2026-2027."

O'Regan said that as a result of SSE's focus on renewables, networks and system flexibility, it was a "key delivery partner" in the UK's Clean Power Action Plan.

"As we look to the opportunities presented by decarbonisation our focus remains on capital discipline, strategic delivery and the efficient operation of our value-creating assets."

At 0818 GMT, shares in SSE were down 0.77% at 1,602.5p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.